CYCN   $0.8148  -0.84% Market Closed

Cyclerion Therapeutics Inc
Last Events:

2023-03-29 Trend pattern changed from расходящийся клин с наклоном вниз to нисходящий клин.

2023-03-29 Signal in RSI changed from bullish to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: entrance to the overbought zone.

2023-03-29 Trend pattern changed from нисходящий клин to расходящийся клин с наклоном вниз.

2023-03-29 Signal in RSI changed from bullish weakening to bullish. RSI indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: entrance to the overbought zone.

2023-03-28 Trend pattern changed from расходящийся клин с наклоном вниз to нисходящий клин.

2023-03-28 Signal in RSI changed from bullish to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: entrance to the overbought zone.

2023-03-28 Trend pattern changed from нисходящий клин to расходящийся клин с наклоном вниз.

2023-03-28 Signal in RSI changed from bullish weakening to bullish. RSI indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: entrance to the overbought zone.


Current temperature: 0.89
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 0.52
Target: 4.00
High with 49% probability: 1.76
Analyst Recommendations:
Number of estimates 1
Target Price Mean 4.00
Mean unverified/preliminary 4.00 / 4.00
Target Price Low / High 4.00 / 4.00
Median / STD DEV 4.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd Sell - -
stoch Sell Sell Sell
ma20 - - -
ma50 - - -
ma100 - - -
Candlestick PatternMarch 13, 2023 Inverted Hammer - is a candlestick that consists of a small body near the low with a little or no lower shadow and a long upper tail. Considered to be a bullish reversal pattern.
ISIN US23255M1053
ceo Dr. Peter M. Hecht Ph.D.
Website https://www.cyclerion.com
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.